Introduction
In the creation of the innate immune response, for example against various pathogens or tumor cells, the most important aspect is the function of cytokines such as interferons (IFNs), tumor necrosis factors (TNFs), certain interleukins (IL-10, IL-12, IL-18), chemokines (RANTES, MIP-1α and-β) and nitric oxide [1, 2] . In innate antiviral immunity reactions several cytokines are engaged. The most important are IFNs, TNF-α, IL-10 and IL-12. Deficiencies in innate immunity can be partial or complete quantitative and functional changes within the mechanisms of the immune system. These deficiencies can sometimes appear unusual, but the most common symptoms are chronic, difficult to treat and recurrent infections of the respiratory tract and skin. Human herpesvirus 1 (HHV-1) and other viral infections also have a difficult course in the case of a shortage of IFNs [3, 4] . Deficiency in cytokine-dependent resistance of human leukocytes was accompanied by frequent upper respiratory tract infections, as well as activation of HHV-1 virus from the state of latency and was also observed in cancer [5] [6] [7] . Lack of effective removal of betaamyloid deposits caused an increase of inflammation in the brain, which can lead to latent HHV-1 activation and induction of neurodegenerative processes [8] . An over-activated innate immune response is as dangerous as innate deficiency and can lead to the development of autoimmune diseases and neurodegenerative disorders. In the regulation of processes controlled by the central nervous system (CNS), cytokines, which are mediators of intercellular signaling, are involved. The reactions of the immune system intensify with increasing amounts of deposition of pathological proteins. Amyloidbeta (Aβ) as large aggregates form senile plaques, which then activate microglia cells and stimulate them to produce large amounts of cytokines, inducing and sustaining a state of inflammation [9] [10] [11] . Deficiency and over-activated innate immune response point to the necessity to investigate different preparations with immunoregulatory activity. Immunotherapy, especially with natural preparations (phytotherapy), could be important in the treatment of many immunodeficiency and inflammatory or infectious diseases.
It is well known that plants are a very rich source of different therapeutic agents. Most active substances obtained from plants are used in organic synthesis to form new drugs. It is estimated that 25% of prescribed drugs worldwide for diseases such as cancer or Alzheimer's disease are derived from plant precursors [12] [13] [14] . Nowadays, medical extracts of Ginkgo biloba L. (Ginkgoaceae) dried leaves are common in Europe and USA and can be purchased as tablets, liquids or injectable solution [15] . Flavonoids and terpenoids, two main fractions of EGb 761, determine its unique pharmacological actions. The most important are antiapoptotic, anti-oxidant and anti-inflammatory activity [12, [16] [17] [18] . It is believed that these properties of the extract also positively affect the immune system. But there is no information available on the effects of EGb 761 on the mechanisms of innate immune response.
Previously we have demonstrated that EGb 761 strongly stimulates innate antiviral immunity of human peripheral blood leukocytes, measured by the resistance to vesicular stomatitis virus (VSV) infection. The effect was more noticeable than in the case of synthetic donepezil, which confirmed the effectiveness of the natural preparation [19] . Here we considered the possible influence of EGb 761 on cytokine production by human peripheral blood leukocytes (PBLs) ex vivo.
Experimental Procedures

Isolation of peripheral blood leukocytes (PBLs)
PBLs from healthy young volunteers, 20-40 years old (n=15, male 7, female 8) were isolated as previously described [19] .
EGb 761
The ). EGb 761 is a standardized preparation with 24% flavones and 6% terpenes including bilobalide.
Virus
Vesicular stomatitis virus (VSV), Indiana strain, Rhabdoviridae, was propagated and titrated in L 929 cells. The titer of the virus was expressed with reference to the value of TCID 50 (tissue culture infectious dose based on the cytopathic effect caused by the virus in about 50% of the infected cells).
Cell lines
L 929 cells (ATCC CCL 1), a murine fibroblast-like cell line, were maintained in Eagle's medium (Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (IIET, PAS) with 10% c.s., antibiotics (100 U mL -1 penicillin and 100 μg mL -1 streptomycin) (Sigma-Aldrich, Poland), and 2 mmol L-glutamine (Sigma-Aldrich, Poland).
A 549 cells (ATCC CCL 185), a human epithelial-like cell line, were maintained in Dulbecco medium (IIET, PAS) with 10% c.s., antibiotics (100 U mL -1 penicillin and 100 μg mL -1 streptomycin) (Sigma-Aldrich, Poland), and 2 mmol L-glutamine (Sigma-Aldrich, Poland).
Trypan blue staining for cell viability
24-hour cultures of L 929 and A 549 cell lines and freshly isolated PBLs were treated with different concentrations of EGb 761 (0-500 μg mL -1 ). The cultures were then incubated for 72 h at 37°C. Morphological changes to the cells were observed every day using an inverted microscope. Total number and viability were determined by 0.4% trypan blue (Sigma-Aldrich, Poland) staining in a Bürker chamber as previously described [19] .
Determination of the virucidal effect of the EGb 761
Viruses at a concentration 2 log TCID 50 were treated for 2 h with different doses of extract. After incubation VSV was titrated in L 929 .
PBLs incubation with EGb 761
Isolated PBLs were divided into two parts. One part of the isolated human PBLs (2x10 6 cells mL -1
) were infected with a VSV dose of 100 TCID 50 . After 40 min of adsorption, the virus was washed out three times with 5 mL of Dulbecco medium and the cells were suspended in 1 mL of Dulbecco's medium with 2% c.s. Next leukocytes were incubated at 37°C with different doses of EGB 761 (0-100 μg mL
). The second part of the cells (2x10 6 cells mL -1 ) were suspended in 1 mL of Dulbecco's medium with 2% c.s and incubated at 37°C with different doses of EGB 761 (0-100 μg mL -1 ). Samples of medium above the VSV-infected and uninfected leukocytes were collected each day (three days of incubation) and stored at -80°C for analysis at a later time.
Cytokine assay
Cytokine levels were determined in the supernatants of cell cultures using ELISA kits (Biomedical Laboratories, USA; BD Biosciences, USA) for human IFNα, IFNγ, TNFα, IL-12 and IL-10 according to the producers' instructions. The optical density was measured at 450 nm using a Multiskan RC spectrophotometric reader (Thermo Labsystems, USA). Cytokine concentrations were expressed in pg/ml.
Statistical analysis
Friedman ANOVA and the post hoc Wilcoxon test with Benjamini-Hochberg correction was used for comparisons between groups. Results are presented as the mean, standard error, and non-outlier range. Results were regarded as statistically significant at P<0.05. All calculations were performed with the R environment (www.r-project.org).
Results
Determination of cytotoxicity of EGb 761
In experiments with EGb 761 cell lines L 929 and A 549 and PBLs of healthy donors were used EGb 761 did not display toxicity to L 929 , A 549 cells or PBLs at the concentrations of 5-100 μg mL -1 ; the cell viability was 90-100%. Only on the third day of incubation shrinkage of the cells and decrease of the cell viability at a dose of 150 μg mL -1 were observed (data not shown). Concentrations greater than 150 μg mL -1 showed high toxicity with a greater number of cells showing altered morphology and by decreased cell viability. Figure 1 shows the morphological changes of cells lines and leukocytes observed after treatment with selected doses of EGb 761 (0, 100, 200 μg mL -1 ). The suspension of EGb 761 extract was prepared in DMSO; therefore it was also necessary to check whether this solvent itself had any toxic effect on the cells. For this purpose, the 24-hour cell cultures and leukocytes were treated with different concentrations of DMSO (0-500 μl mL -1 ). Changes in the morphology of the cells were observed every day using an inverted microscope. Also, total number and viability were determined by 0.4% trypan blue staining. No toxic effects of DMSO at 5-250 μl mL -1 were observed. The concentration 500 μl mL
of DMSO resulted in cell shrinkage and yielded a cell viability of under 90% (data not shown).
As we mentioned earlier [19] 
Influence of EGb 761 on cytokine production
Here we demonstrated the effects of EGb 761, the natural drug, on the production of cytokines IFN-α, IFN-γ, TNF-α, IL-10 and IL-12 by human uninfected and VSVinfected PBLs ex vivo. Cytokine concentrations were measured by ELISA. Samples of supernatants were collected for 3 days from VSV-infected and uninfected leukocytes incubated at 37°C in the presence of selected concentrations of EGb 761 (25, 50 and 100 μg mL -1 ).
TNF-α
Studies on the impact of EGb 761 on the production of TNF-α by PBLs yielded very interesting results. The extract showed an influence on the production of TNF-α. A strongly inhibitory effect at all concentrations of EGb 761 on VSV-infected human leukocytes was observed at the third day of incubation. The results are shown in Figure 2 and Table 1 .
IFNs
EGb 761 reduced IFN-α production by human PBLs. The effect was observed in VSV-infected leukocytes after 24 and 48 h of incubation with all applied concentrations of EGb 761. There was no spontaneous secretion of Figure 2 . Effect of EGb 761 on TNF-α production by human VSV-infected PBLs (n=15). PBLs at a concentration 2×10 6 IFN-α by PBLs. The effect of EGb 761 application on IFN-γ production by human PBLs was well-defined. EGb 761 strongly increased the level of IFN-γ on each day of incubation by VSV-infected and uninfected PBLs. The effect was also dose-dependent. Averaged results of both IFNs are shown in Figure 3 and Table 1 .
IL-10, IL-12
The effect of EGb 761 on IL-10 and IL-12 production was studied. EGb 761 decreased the production of IL-10 by VSV-infected and uninfected PBLs at all applied concentrations, on each day of incubation. In the case of IL-12, EGb 761 significantly decreased the production by VSV-infected leukocytes. The effect was observed after 24 h incubation with all depleted concentrations.
Results for IL-10 and IL-12 are shown in Figure 4 and summarized in Table 1 . 
Discussion
Mechanisms of innate immunity such as the production of cytokines, chemokines and adhesion molecules often determine the course of many diseases. In the pathogenesis of diseases where inflammation may contribute to disease progression, like autoimmune or neurodegenerative disorders, or in infectious diseases, modulation of pro-and anti-inflammatory cytokine production using natural herbal supplements, such EGb 761, may play an important role as a supporting therapy. EGb 761 is a well-defined complex mixture of compounds and is a non-toxic drug. Currently it has been introduced in the clinic for the treatment of vascular dementia and Alzheimer's disease (mixed dementia), tinnitus, vertigo and Parkinson disease [20] . 19 dementia experts, participants of "The Ageing Brain" meeting on Ginkgo biloba special extract EGb 761 ® , which took place in 2011 in Amsterdam, concluded that many pre-clinical and clinical research confirmed the positive effect of the compound and future research with the extract targeting cognitive impairment in old age should be considered [21] . Thus, future studies using EGb 761 will be conducted to determine the activity of the extract in relation to cytokine production and activation of transcription factors by leukocytes of patients with Alzheimer's disease.
In the light of our research, EGb 761 may also be a good candidate for the investigation of its usefulness in strengthening the innate immunity reactions. Here we present the immunoregulatory activity of EGb 761 on cytokine production, one of the innate antiviral immunity reaction, by human PBLs ex vivo from healthy blood donors. Furthermore, we discuss the immunoregulatory activity of the EGb 761 in comparison to the synthetic drug donepezil, previously tested by our laboratory.
We demonstrated earlier that donepezil strongly reduced the production of TNF-α in both infected and uninfected PBLs ex vivo [22] . The inhibitory effect was dose-dependent. Decrease in the production of proinflammatory cytokines such as TNF-α, IL-1 or IL-6 by leukocytes isolated from patients with Alzheimer's disease before and after months of donepezil therapy was also observed by two other teams: Reale and colleagues [23] and Gambi and colleagues [24] . We have mentioned that the synthetic drug donepezil inhibited IFN-α, IFN-γ and IL-10 production. An effect on IL-12 production was not observed. The results of this study show a different effect of EGb 761, a natural drug, on cytokine production by human PBLs ex vivo. The extract strongly increased IFN-γ production. These investigations are contrary to the results obtained by Cheng and colleagues [25] . Perhaps the difference in results arises from the fact that their research concentrated on the production of interferon only by human T lymphocytes in vitro while our studies look at the entire leukocyte population. IFN-γ is a cytokine that has been implicated in both neural damage and repair. Treatment of neuronal cells with IFN-γ increased neuronal death in response to amyloid-beta (1-42) [26] . However, many recent investigations have shown that IFN-γ protects against neuronal damage rather than damaging the neurons. IFN-γ pretreatment protects microglial cells from oxidative stress [27] and preserves hippocampal neurons against excitoxicity [28] . According to Baron and colleagues [29] , immunomodulation of IFN-γ production is very important in the course of neurodegenerative diseases. They noted that limited amounts of IFN-γ in the brain can significantly enhance the process of neurogenesis in the dentate gyrus of adult mice and improves the spatial learning and memory performance of the animals. In the present study, we demonstrated that EGb 761 significantly decreased the level of IFN-α, IL-10 while a not so dramatic decrease in the production of IL-12 and TNF-α was observed. Jiao and colleagues [30] showed that EGb 761 inhibited the production of proinflammatory cytokines TNF-α, IL-1β and IL-6, but strongly increased the expression of IL-10 in rat brain tissue. Reduction of TNF-α production by LPS-activated macrophages after the administration of EGb 761 was also observed by Wadsworth and colleagues [31] . They found that EGb 761 and quercetin, the main component of the preparation, firmly reduced the level of TNF-α at the post-transcriptional step. However, this effect was only marginally associated with inhibition of the NFκB activation. Recently, Ching-Hsiang and colleagues [32] report that there were no significant changes in serum level of TNF-α from patients suffering from chronic, age-related neurological disorders, after EGb 761 treatment. The different effect of EGb 761 and donepezil on the production of TNF-α and IFN-γ observed in our studies was probably related to impact on different signaling peptides or transcription factors. Thus, future investigations to clarify the mechanism of EGb 761 activity are necessary. Most of the results of multicenter studies indicated anti-inflammatory activity of the extract of G. biloba [33] , which may also have therapeutic importance in the treatment of inflammatory diseases. Park and colleagues [34] suggested that the different effect on cytokine production may result from the different content of the particular components of the extracts of G. biloba. They showed that EGb 761 but not GBB had a stronger effect on the level of TNF-α production. They suggested that this was connected with the higher content of the terpene fraction (up to 12% terpenes in GBB, about 6% in EGb 761), but also with the contents of glycoside flavones. In our laboratory studies, however, we noticed that flavones such as wogonin or baicalein, isolated from Scutellaria baicalensis, had different activity. These substances stimulated the production of IL-10, IL-12 and TNF-α, and lowered interferon levels [35] . In view of the different roles of cytokines in various conditions, their significance must be carefully analyzed.
Conclusions
Natural drugs, like EGb 761, with potent immunoregulatory properties may be very promising for administration in cases of harmful immune responses observed in infectious disease, chronic inflammation and autoimmunity or neurodegenerative disorders. Currently, many studies have demonstrated the antioxidant or anti-inflammatory activities of EGb 761 with beneficial effect on the circulatory system and nervous system. While little data on the direct effect of the extract on mechanisms of innate immunity is available. The first data on potential immunostimulatory activity of the extract, in addition to its broad spectrum of pharmacological effects, were presented by Villaseñor-García and colleagues [36] and Puebla-Pérez and colleagues [37] . Thus, further studies on the effects of EGb 761 on the different mechanisms of innate immunity are required.
